Biotech

All Articles

A better take a look at Intense Biotech's Intense 15

.In this particular full week's incident of "The Top Line," our experts are actually diving into Fer...

Lilly deals with period 2 failing of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's event commemorating the commendation...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of substantial management hirings, firings a...

Lykos will definitely talk to FDA to reexamine its own decision observing turndown of MDMA treatment for trauma

.Complying with an inadequate showing for Lykos Therapeutics' MDMA prospect for trauma at a latest F...

AN 2 fifty percents head count, quits stage 3 test after information let down

.AN2 Therapeutics is actually reviewing its own company in reaction to poor midphase records, vowing...

Merck pays out $700M for bispecific, snooping autoimmune position as well as opportunity to challenge Amgen in cancer cells

.Merck &amp Co. is actually paying for $700 thousand in advance to challenge Amgen in a blood cancer...

Gilead pays out J&ampJ $320M to go out licensing bargain for seladelpar

.With Gilead Sciences almost an FDA decision for its liver condition drug seladelpar, the firm has p...

' All hands on deck' at Lilly as peers target weight problems market

.Chief executive officer David Ricks may see the firms setting up outdoors tents at basecamp behind ...

Entero laying off workers, moving out of office and also stopping R&ampD

.Cushion Liquidators has transformed Entero Rehabs white as a sheet. The financial institution bough...

Exelixis goes down ADC after choosing it's no match for Tivdak

.Exelixis is losing hope on its tissue variable (TF)- targeting antibody-drug conjugate after conclu...